Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 3rd Edition
Date of Publication: 02/2025
This item will be released on 03/02/2025. Pre-order now and we will deliver on the release date.
Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 3rd Edition builds on the same foundation of clearly explained, up-to-date, and clinically current content as Lehne’s trusted undergraduate text, while focusing on the information that advanced practice nurses and Physician Assistants specifically need for safe and effective prescribing. Introductory chapters provide foundational content in the areas of prescriptive authority, rational drug selection, prescription writing, and promoting positive outcomes of drug therapy. Core drug chapters focus on the drugs that you will most commonly see in clinical practice. Pharmacotherapeutic decision-making is emphasized, with Black Box Warnings and new Drug Decision Guide boxes. This edition features completely updated content with new chapters on drugs for sexual dysfunction and drugs for transgender health. It’s everything you need to be a safe and effective prescriber!
Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 3rd Edition builds on the same foundation of clearly explained, up-to-date, and clinically current content as Lehne’s trusted undergraduate text, while focusing on the information that advanced practice nurses and Physician Assistants specifically need for safe and effective prescribing. Introductory chapters provide foundational content in the areas of prescriptive authority, rational drug selection, prescription writing, and promoting positive outcomes of drug therapy. Core drug chapters focus on the drugs that you will most commonly see in clinical practice. Pharmacotherapeutic decision-making is emphasized, with Black Box Warnings and new Drug Decision Guide boxes. This edition features completely updated content with new chapters on drugs for sexual dysfunction and drugs for transgender health. It’s everything you need to be a safe and effective prescriber!
Key Features
- UPDATED! Content throughout reflects the latest drug information and evidence-based treatment guidelines and protocols.
- NEW! Drugs for Sexual Dysfunction and Drugs for Transgender Health chapters in a newly combined Reproductive Health unit promote health equity.
- NEW! Drug Decision Guide boxes for selected drugs emphasize a rational process for drug selection.
- NEW! Clinical Pearls boxes highlight expert tips for rational drug prescription.
- NEW! Chapter-opening Evolve links and “Top 300” drug icons throughout identify drugs that appear on the Top 300 prescribed drug list to help you focus your study time.
- ENHANCED! Introductory chapters emphasize prescriber-level pharmacokinetics and pharmacodynamics content.
- NEW! Coverage addresses immunizations and therapeutics (e.g., Regeneron, Resdemivir, dexamethasone) for SARS-CoV-2 infection (COVID-19).
- UPDATED! Enhanced coverage of sexually transmitted infections reflects the latest evidence-based guidelines.
- NEW! Drug content addresses medications for ectoparasite infestations.
- Introductory chapters tailored to the specific needs of beginning prescribers cover topics such as prescriptive authority, rational drug selection and prescription writing, and promoting positive outcomes of drug therapy.
- Carefully focused pharmacotherapeutics content reflects the drugs most commonly seen and used by primary and acute care prescribers, with an emphasis not on the first drug discovered or developed in each drug class, but on the agents most often used today.
- Chapters address primary care drugs first, as appropriate, followed by acute care drugs.
- Prescriber-focused pedagogical aids further reinforce the most important information for prescribers.
- UNIQUE! Summary of Key Prescribing Considerations at the end of each drug chapter provides a concise summary of essential prescriber information.
- Coverage of interprofessional collaboration addresses the growing global emphasis on interprofessional collaboration and incorporates opportunities for interprofessional collaborative practice throughout.
- Integrated coverage of Canadian trade names appears throughout and is highlighted with a familiar maple-leaf icon.
Author Information
By Laura D. Rosenthal, DNP, RN, ACNP-BC, FAANP, Professor, College of Nursing, University of Colorado Anschutz Medical Campus, Aurora, Colorado and Jacqueline Rosenjack Burchum, DNSc, FNP-BC, CNE, Associate Professor, College of Nursing, Department of Advanced Practice and Doctoral Studies, University of Tennessee Health Science Center, Memphis, Tennessee
